This article was automatically generated by Dow Jones using technology from Automated Insights.
The following companies are among those expected to report their latest financial results before the market opens.
Cardinal Health Inc.'s fourth-quarter EPS is forecast at $1.85, compared with $1.00 in the prior-year period. Adjusted EPS is forecast at $2.42.
$Aramark(ARMK-W)$'s third-quarter EPS is forecast at 43 cents, compared with 27 cents in the prior-year period. Adjusted EPS is forecast at 48 cents.
Silicon Laboratories Inc.'s second-quarter EPS is forecast at a loss of 25 cents, compared with a loss of 67 cents in the prior-year period. Adjusted EPS is forecast at 69 cents.
Middleby Corp.'s second-quarter EPS is forecast at $1.85, compared with $1.99 in the prior-year period. Adjusted EPS is forecast at $2.09.
Tango Therapeutics Inc.'s second-quarter EPS is forecast at a loss of 32 cents, compared with a loss of 35 cents in the prior-year period.
Legend Biotech Corp. ADR's second-quarter EPS is forecast at 6 cents, compared with a loss of 68 cents in the prior-year period.
Vestis Corp.'s third-quarter EPS is forecast at 4 cents, compared with a loss of 1 cent in the prior-year period. Adjusted EPS is forecast at 10 cents.
Aura Biosciences Inc.'s second-quarter EPS is forecast at a loss of 37 cents, compared with a loss of 47 cents in the prior-year period.
Janus International Group Inc.'s second-quarter EPS is forecast at 11 cents, compared with 15 cents in the prior-year period. Adjusted EPS is forecast at 14 cents.
908 Devices Inc.'s second-quarter EPS is forecast at a loss of 19 cents, compared with a loss of 37 cents in the prior-year period. Adjusted EPS is forecast at a loss of 14 cents.
Anavex Life Sciences Corp.'s third-quarter EPS is forecast at a loss of 17 cents, compared with a loss of 16 cents in the prior-year period. Adjusted EPS is forecast at a loss of 0.07 cents.
Chicago Atlantic Real Estate Finance Inc.'s second-quarter EPS is forecast at 43 cents, compared with 41 cents in the prior-year period. Adjusted EPS is forecast at 48 cents.
Neuronetics Inc.'s second-quarter EPS is forecast at a loss of 13 cents, compared with a loss of 15 cents in the prior-year period. Adjusted EPS is forecast at a loss of 12 cents.
Greystone Housing Impact Investors L.P.'s second-quarter EPS is forecast at a loss of 8 cents, compared with a loss of 35 cents in the prior-year period. Adjusted EPS is forecast at 12 cents.
TScan Therapeutics Inc.'s second-quarter EPS is forecast at a loss of 25 cents.
Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.
Comments